Day: October 5, 2023

VANCOUVER, British Columbia, Oct. 05, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NF0) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, is pleased to announce that it has received approval to have the common shares (“Common Shares“) of the Company listed on the Canadian Securities Exchange (the “CSE“). Consequently, the Company has also submitted a request to the NEO Exchange Inc., operating as Cboe Canada (the “NEO“) to delist the Common Shares NEO. The Common Shares are expected to be delisted from the NEO at close of business on October 5, 2023, and will begin trading on the CSE under the...

Toronto, Ontario, Canada, Oct. 05, 2023 (GLOBE NEWSWIRE) — Canada Carbon Inc. (the “Company” or “Canada Carbon” or (“CCB”), (TSX-V:CCB), (FF:U7N1) is pleased to announce it will begin a second phase of drilling on its Asbury Property located in Notre-Dame-du-Laus, Québec (“NDL”). The Company has entered into a contract with George Downing Estate Drilling, Ltd. to execute the drilling program which is expected to commence on or about October 16th, 2023. Additionally, the Company has mandated SGS to complete a calculation of mineral resources in accordance with National Instrument 43-101 on the basis of its Phase 1 drill results (see news release dated March 27th, 2023). A supplemental note to the mineral resource estimate will be issued upon completion of the Phase 2 drill campaign and the...

New results support the neuroprotective effects of ATH-1105 in preclinical models of ALS, as indicated by consistent reduction in plasma neurofilament light chain (NfL) levels and preservation of motor function Data presented at invitational Northeast ALS Consortium (NEALS) meeting BOTHELL, Wash., Oct. 05, 2023 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, presented new preclinical data supporting the potential benefit of ATH-1105 for the treatment of amyotrophic lateral sclerosis (ALS) at the 22nd Annual Northeast ALS Consortium (NEALS) Meeting, taking place October 4-6, 2023, virtually and in-person in Clearwater, Florida. ATH-1105 is an orally administered small molecule therapeutic...

EDEN PRAIRIE, Minn., Oct. 05, 2023 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that CEO Jeff Ross will present at the 2023 Cell & Gene Meeting on the Mesa in Carlsbad, CA. The three-day event, held this year on October 10-12, will feature presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies. Mr. Ross will deliver his remarks at 5:30 pm PT on Wednesday, October 11th in the Ecolab Lifesciences Ballroom. Registration for either in-person attendance or virtual...

AutoTech Breakthrough annual awards program recognizes Arteris’ innovation in automotive and transportation technologies around the globe. CAMPBELL, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP that accelerates system-on-chip (SoC) creation, today announced it is the recipient of the prestigious Autonomous Vehicle Technology of the Year award, conducted by AutoTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global automotive and transportation technology markets. Arteris won the Autonomous Vehicle Technology of the Year award for its latest system IP innovation, announced earlier this year. FlexNoC network-on-chip (NoC) IP for automotive advanced driver-assistance systems (ADAS) chips...

HAUPPAUGE, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company”) today announced that the Company expects to release its earnings for the quarter ended September 30, 2023 before the open of the U.S. equity markets on Thursday, October 19, 2023. The Company will conduct a conference call at 8:30 a.m. (ET) on Thursday, October 19, 2023, during which President and Chief Executive Officer (“CEO”), Stuart Lubow, will discuss the Company’s third quarter financial performance. There will be a question-and-answer period after the CEO remarks. The conference call will be simultaneously webcast (listen only) and archived for a period of one year at https://events.q4inc.com/attendee/616795871. Conference Call Details:Dial-in for Live Call:  United States:International: Access...

The Company acquires 100% of Alchemy Markets DMCC (Alchemy UAE), 100% of Alchemy Prime Ltd. (Alchemy UK), and 49.90% of Alchemy Markets Ltd. (Alchemy Malta). Post-merger, the Company will control 100% of Alchemy Malta. The acquisition of Alchemy UK and Alchemy Malta is subject to regulatory approval. Irvine, CA, Oct. 05, 2023 (GLOBE NEWSWIRE) — FDCTech, Inc. (“FDC” or the “Company,” OTCQB: FDCT), a fintech-driven company specializing in buying and integrating small to mid-size legacy financial services companies, today announced the definitive agreement with Alchemy Group where the Company acquired 100% of Alchemy Markets DMCC (Alchemy UAE), 100% of Alchemy Prime Ltd. (Alchemy UK), and 49.90% of Alchemy Markets Ltd. (Alchemy Malta). After the acquisition of 49.90% of Alchemy Malta, the Company will control...

BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) — Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that the company will release its third quarter 2023 financial results on Wednesday, November 1, 2023, after the financial markets close. The company will host a conference call that same day to discuss its results and business outlook at 4:30 p.m. Eastern Time. The call will be accessible by telephone at +1 888-330-2384 (toll-free) or +1 240-789-2701 with the event code 8484206. The call will also be available live via webcast on the company’s website at https://investors.rapid7.com. A webcast replay of the conference call will be available at https://investors.rapid7.com. About Rapid7Rapid7 (Nasdaq: RPD) is on a mission to create a safer digital world by making cybersecurity simpler and more accessible....

UPPSALA, Sweden, Oct. 05, 2023 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (Nasdaq: OLK) today reported the publication of three articles in the prestigious scientific journal, Nature, that demonstrate the power of the Olink Explore platform for driving impactful proteogenomic studies at the population scale. The studies each used data generated from the UK Biobank Pharma Proteomics Project (UKB-PPP), whereby 13 biopharmaceutical companies generated new proteomic data from accessing the UK Biobank. Using the Olink Explore platform, researchers measured around 3,000 proteins in more than 54,000 UKB participant samples. By combining genomic and proteomic analyses at an unprecedented scale, a wealth of new information is available on the genetic effects on protein expression and phenotypic outcomes. The findings illustrate the immense...